156 related articles for article (PubMed ID: 29535129)
1. Report of the 14th International Conference on Malignant Lymphoma (ICML) Closed Workshop on Future Design of Clinical Trials in Lymphomas.
Stathis A; Iasonos A; Seymour JF; Thieblemont C; Ribrag V; Zucca E; Younes A
Clin Cancer Res; 2018 Jul; 24(13):2993-2998. PubMed ID: 29535129
[TBL] [Abstract][Full Text] [Related]
2. Follicular lymphoma: State-of-the-art ICML workshop in Lugano 2015.
Gascoyne RD; Nadel B; Pasqualucci L; Fitzgibbon J; Payton JE; Melnick A; Weigert O; Tarte K; Gribben JG; Friedberg JW; Seymour JF; Cavalli F; Zucca E
Hematol Oncol; 2017 Dec; 35(4):397-407. PubMed ID: 28378425
[TBL] [Abstract][Full Text] [Related]
3. The development of liquid biopsy for research and clinical practice in lymphomas: Report of the 15-ICML workshop on ctDNA.
Rossi D; Kurtz DM; Roschewski M; Cavalli F; Zucca E; Wilson WH
Hematol Oncol; 2020 Feb; 38(1):34-37. PubMed ID: 31872890
[TBL] [Abstract][Full Text] [Related]
4. Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002.
Ferreri AJ; Abrey LE; Blay JY; Borisch B; Hochman J; Neuwelt EA; Yahalom J; Zucca E; Cavalli F; Armitage J; Batchelor T
J Clin Oncol; 2003 Jun; 21(12):2407-14. PubMed ID: 12805341
[TBL] [Abstract][Full Text] [Related]
5. Highlights in lymphoma: overview of the 11th International Conference on Malignant Lymphoma.
Chiappella A; Vitolo U
Expert Rev Hematol; 2011 Oct; 4(5):491-4. PubMed ID: 21939417
[TBL] [Abstract][Full Text] [Related]
6. Staging and response assessment in lymphomas: the new Lugano classification.
Cheson BD
Chin Clin Oncol; 2015 Mar; 4(1):5. PubMed ID: 25841712
[TBL] [Abstract][Full Text] [Related]
7. 17th International Conference on Malignant Lymphoma: Key Takeaways.
Blood Cancer Discov; 2023 Sep; 4(5):342-345. PubMed ID: 37540826
[TBL] [Abstract][Full Text] [Related]
8. Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3-5 October 2012.
Meignan M; Barrington S; Itti E; Gallamini A; Haioun C; Polliack A
Leuk Lymphoma; 2014 Jan; 55(1):31-7. PubMed ID: 23763460
[TBL] [Abstract][Full Text] [Related]
9. Happy anniversary to the 10th ICML--International Conference on Malignant Lymphoma in Lugano, 4-7 June 2008With a personal tribute to the conference president and founder of ICML--Professor Franco Cavalli.
Polliack A; Seymour J
Leuk Lymphoma; 2008 Oct; 49(10):1839-40. PubMed ID: 18949605
[No Abstract] [Full Text] [Related]
10. Highlights in Lymphoma From the 13th International Conference on Malignant Lymphoma. A Review of Selected Presentations From the 13th International Conference on Malignant Lymphoma • June 17-20, 2015 • Lugano, Switzerland.
Moskowitz CH
Clin Adv Hematol Oncol; 2015 Aug; 13(8 Suppl 9):1-23. PubMed ID: 26452080
[No Abstract] [Full Text] [Related]
11. Epidemiology and management of lymphoma in low-income countries.
Zucca E; Rohatiner A; Magrath I; Cavalli F
Hematol Oncol; 2011 Mar; 29(1):1-4. PubMed ID: 21381073
[TBL] [Abstract][Full Text] [Related]
12. Report on the FDA-AACR Immuno-oncology Drug Development Workshop.
Curran C; Sharon E
Cancer Immunol Res; 2017 Apr; 5(4):282-285. PubMed ID: 28373216
[TBL] [Abstract][Full Text] [Related]
13. Discovery Science highlights from the 17th International Conference on Malignant Lymphoma.
Forestieri G; de Almeida JM; Napoli S; Piffaretti D; Tarantelli C; Zhang F; Mensah AA
Hematol Oncol; 2024 May; 42(3):e3275. PubMed ID: 38650582
[No Abstract] [Full Text] [Related]
14. Biomarkers and prognosis in malignant lymphomas.
Hagenbeek A; Gascoyne RD; Dreyling M; Kluin P; Engert A; Salles G
Clin Lymphoma Myeloma; 2009 Apr; 9(2):160-6. PubMed ID: 19406728
[TBL] [Abstract][Full Text] [Related]
15. First meeting of the European canine lymphoma group. Workshop: state of the art and comparative aspects in canine lymphoma. CH-Lugano, 22 June 2013.
Comazzi S; Guscetti F; Marconato L
Hematol Oncol; 2014 Jun; 32(2):68-71. PubMed ID: 24193915
[TBL] [Abstract][Full Text] [Related]
16. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.
Lieberman R; Nelson WG; Sakr WA; Meyskens FL; Klein EA; Wilding G; Partin AW; Lee JJ; Lippman SM
Urology; 2001 Apr; 57(4 Suppl 1):4-27. PubMed ID: 11295590
[TBL] [Abstract][Full Text] [Related]
17. [Staging and Treatment Response Evaluation in Malignant Lymphomas - Czech Lymphoma Study Group Recommendations According to Criteria Revised in 2014 (Lugano Classification)].
Sýkorová A; Pytlík R; Móciková H; Belada D; Benešová K; Papajík T; Janíková A; Šálek D; Procházka V; Vokurka S; Campr V; Klener P; Kubáčková K; Trněný M
Klin Onkol; 2016; 29(4):295-302. PubMed ID: 27534788
[TBL] [Abstract][Full Text] [Related]
18. International Central Nervous System and Ocular Lymphoma Workshop: recommendations for the future.
Nussenblatt RB; Chan CC; Wilson WH; Hochman J; Gottesman M;
Ocul Immunol Inflamm; 2006 Jun; 14(3):139-44. PubMed ID: 16827214
[TBL] [Abstract][Full Text] [Related]
19. International harmonization of trial parameters in malignant lymphoma.
Pfistner B; Diehl V; Greb A; Cheson B
Eur J Haematol Suppl; 2005 Jul; (66):53-4. PubMed ID: 16007869
[TBL] [Abstract][Full Text] [Related]
20. The problem of classifying lymphomas: an orderly prescription for progress.
Berard CW; Hutchison RE
Ann Oncol; 1997; 8 Suppl 2():3-9. PubMed ID: 9209632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
